Article
Underrepresentation of Dermatologic Conditions in POC
September 23, 2022
PHM Session: Dermatologic Disease Presentations, Skin Color, and Disparities in Medical Care Presenters: Deawodi Ladzekpo, MD, and Sonya Tang Girdwood, MD, PhD, Cincinnati Children’s Hospital,...
![1]()
News
Care via video teleconferencing can be as effective as in-person for some conditions
December 6, 2021
Video teleconferencing works best for monitoring patients with chronic conditions, according to the author of a new paper.
News
New virus causing ‘Alaskapox’ detected in two more cases
September 24, 2021
Sampling of the pox mark showed that it was caused by a previously unidentified virus of the same family as smallpox and cowpox.
News
Psoriasis associated with an increased risk of COVID-19 in real-world study
April 28, 2021
Those treated with TNF-alpha inhibitors, methotrexate, and apremilast had statistically lower risks of COVID-19 vs. those on topical therapy.
News
Blacks and Hispanics have higher inpatient use for mycosis fungoides
April 15, 2021
Findings reinforce need to maintain “higher index of suspicion” in these patients.
![1]()
News
Data about COVID-19-related skin manifestations in children continue to emerge
April 14, 2021
Of 50 hospitalized children infected with COVID-19, 18 (36%) fulfilled criteria for Multisystem Inflammatory Syndrome in Children.
![1]()
News
Are there COVID-19–related ‘long-haul’ skin issues?
January 28, 2021
Dr. Freeman believes that pernio and especially persistent lesions are caused by an immune response to COVID.
![1]()
News
COVID-19 vaccines: Safe for immunocompromised patients?
December 17, 2020
Data are limited thus far, and the safety and efficacy of the COVID-19 vaccines in immunocompromised patients remain unknown.
![1]()
News
What happened to melanoma care during COVID-19 sequestration
November 11, 2020
Preliminary evidence indicates delayed diagnosis and treatment measurably worsened outcome indicators.
News
Biologics may protect psoriasis patients against severe COVID-19
November 2, 2020
Preliminary evidence suggests biologics prevent the fearsome COVID-19 late cytokine storm.
